Banner Ridge Partners, a $7.3 billion multi-strategy private equity investment firm, has completed fundraising for Banner Ridge Secondary Fund V at its hard cap with $2.15 billion of total commitments. BRP V is the latest fund to be raised as part of the firm's flagship secondary program.
Palo Alto-based investment firm TCG Crossover Closes TCGX Fund II with $1B in capital. The offering attracted strong support from new and existing limited partners with commitments coming globally from investors in North America, Europe, the Middle East, and Asia.
Varlo Sports, a trailblazing company at the intersection of design and performance in the sports apparel industry, proudly announces the successful completion of its most recent seed funding round. This significant milestone ensures the company's continued growth and operational excellence as it embarks on its next chapter in 2024.
California-based Hyperlink Ventures secures $32 million for its first fund. Twenty limited partners, includes family offices in the US and Israel and former company founders,...
NYC-based Qortex Secures $10m in Funding. GFT Ventures led the investment, with Silicon Road Ventures joining in. In order to meet customer and market...
Brazil-based Emergent Cold LatAm secures US$500M in funding. The lead investors in the round were Stonepeak, Lineage and Losa Group.
Read also - San Francisco-based...
ProHance Secures Majority Investment from ChrysCapital. The deal's total value was not made public. The corporation is going to use the funds to fortify...
Resurgens Technology Partners, a software-focused private equity firm announced its investment in Valant, a cloud-based EHR for behavioral health practices.
Durin Technologies announced funding of $3.5 million led by Breakthrough Diagnostics, LLC. The funding will accelerate Durin’s next key stages of anticipated growth, involving commercialization of its novel diagnostic tests focusing on Alzheimer’s and Parkinson’s diseases and development of its next generation of diagnostic tests that detect other diseases and disorders at their earliest stages.
